Bios Fund II NT, LP

Track

Insider profile

Bios Fund II NT, LP's trades of Lantern Pharma Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
379.80
Quantity 2,242
Value US$1,878,715
Transaction date
Proposed sale
Price
66.47
Quantity 27,625
Value US$4,171,232
Transaction date
Proposed sale
Price
396.74
Quantity 5,954
Value US$390,653
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-27 2025-05-27
PrS Proposed sale
2,242
379.80
US$1,878,715 		2,242 379.80 US$1,878,715
2024-04-26 2024-04-29
PrS Proposed sale
27,625
66.47
US$4,171,232 		27,625 66.47 US$4,171,232
2024-02-28 2024-02-27
PrS Proposed sale
5,954
396.74
US$390,653 		5,954 396.74 US$390,653